超声检查率的差异反映了甲状腺癌中的性别差异
该回顾性队列研究纳入1997至2019年Kaiser Permanente Washington的33589例接受甲状腺超声的成人,分析超声、细针穿刺活检(FNAB)和癌症发病率随性别的变化。结果显示男性超声率增长五倍、女性增长超过四倍,男性每超声FNAB率高于女性(调整率比=1.06,CI 1.01-1.11),但每FNAB癌症诊断率两性相似(均为0.06,p=0.4),提示超声率差异可能是甲状腺癌发病率性别差异的驱动因素。
要点
- 1997至2019年男性甲状腺超声率增长五倍(111.11-490.97/10万),女性增长超过四倍(382.27-1331.14/10万)。
- 男性每超声FNAB率高于女性(调整率比=1.06,CI 1.01-1.11),且随时间变化不大。
- 两性每FNAB癌症诊断率相似(均为0.06,p=0.4)。
核心结论
- 甲状腺超声率的性别差异显著,可能是甲状腺癌发病率性别差异的驱动因素。
- 超声触发的FNAB在男性中更常见且随时间变化不大,挑战了女性甲状腺癌发病率高得多的主流认识。
- 尽管两性在人群层面的FNAB和癌症差异很大,但在接受超声的人群中差异很小。
研究设计与样本
- 纵向回顾性队列研究,纳入Kaiser Permanente of Washington的18岁及以上参保者,1997至2019年接受甲状腺超声,数据包括电子账单索赔和肿瘤登记诊断。
- 共33589例患者接受超声,其中78%为女性,平均年龄56岁。
- 使用带偏移项的泊松模型分析性别与需FNAB的超声比例的关系,并调整患者和社会人口学特征。
主要发现
- 每10万参保人的超声率:男性从111.11增至490.97(增长五倍),女性从382.27增至1331.14(增长超过四倍)。
- 每10万参保人的FNAB率:女性从174.09增至430.37,男性从58.38增至189.13。
- 总体每超声FNAB率随时间变化不大,男性高于女性(调整率比=1.06,CI 1.01-1.11)。
- 研究期间女性癌症发病率更高,但每FNAB癌症诊断率两性相似(均为0.06,p=0.4)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Expanding ultrasound use has increased the detection of thyroid cancer. Incidence has always been higher among females, a disparity that has grown over time. The sex difference in thyroid cancer is understudied in the context of diagnostic testing, particularly among privately insured adults in whom thyroid cancer is most common. We evaluated the association between thyroid ultrasound, fine needle aspiration biopsy (FNAB), and cancer incidence by sex in a large, integrated health system. Methods: This longitudinal retrospective cohort study included Kaiser Permanente of Washington enrollees aged 18 and over who underwent thyroid ultrasound from 1997 to 2019. Data included electronic billing claims for patients linked to tumor registry diagnoses. We estimated (1) annual overall ultrasound, FNAB, and cancer incidence rates; (2) the proportion of ultrasound requiring FNAB; and (3) cancer diagnoses per FNAB. A Poisson model with offset determined the relationship between sex and the proportion of ultrasound requiring FNAB adjusting for patient and sociodemographic characteristics. Results: A total of 33,589 patients underwent ultrasound (78% females; mean age 56). Ultrasound rates per 100,000 covered lives, defined as insured individuals per year, increased five-fold among males (111.11-490.97) and >four-fold among females (382.27-1331.14) between 1997 and 2019. FNAB rates also increased over time (rates per 100,000: 174.09-430.37 in females vs. 58.38-189.13 in men). Overall, FNAB rates per ultrasound changed little over time, and FNAB per ultrasound was greater in males compared with females (Adj rate ratio = 1.06 [confidence interval 1.01-1.11]). Cancer incidence was higher in females over the study period, but cancer incidence per FNAB was similar between sexes (both 0.06, p = 0.4). Conclusions: Sex disparities in thyroid ultrasound rates are stark and are a likely driver of sex disparities in thyroid cancer incidence. Interestingly, ultrasound-triggered FNAB was more common in males and changed little over time, challenging the prevailing understanding that females have much higher rates of thyroid cancer. Although the population-based differences between sexes for FNAB and cancer were large, the differences among people who had ultrasound were small.
引用
- Fernandes-Taylor S, Bowles EJA, Venkatesh M, et al. Differential Ultrasound Rates Mirror Sex Disparities in Thyroid Cancer. Thyroid. 2024. PMID: 39607408. doi:10.1089/thy.2024.0344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。